Celly LLC is taking Russian medical technologies to the global stage, offering a revolutionary approach to blood analysis with AI. The idea that neural networks could revolutionize diagnostics was conceived early on. In 2019, the company underwent acceleration in Silicon Valley, where it gained valuable experience in building a high-tech business and attracted its first investments. Despite the opportunity to develop in the West, Celly's management decided to remain in Russia, seeing a strong engineering base and easier access to talented specialists here. The strategy was to develop and test the product in Russia, and then scale it globally.
In 2022, the company released the first version of its product and became a Skolkovo resident. By 2024, Celly device successfully completed clinical trials, demonstrating that its diagnostic accuracy is comparable to competing solutions tens of times more expensive. In 2025, the company underwent certification in the Russian Federation and started active scaling, including expansion into international markets.
Blood smear analysis is one of the most common laboratory tests worldwide, used to diagnose infectious diseases, anemia, and leukemia. Approximately 600 million such tests are performed annually, but most are performed manually due to the high cost of automated systems. Manual analysis suffers from subjectivity, inattention, and a shortage of qualified personnel.
Celly offers an automated yet affordable solution. It's a kit that transforms a standard laboratory microscope into a digital blood smear scanner. It consists of a smartphone with the Celly mobile app, a special lens adapter for connecting to the microscope, a robotic slide handling system, and cloud storage. The product performs automated CBC analysis, replacing manual labor, and is 10 times cheaper than existing solutions from giants like Mindray and CellaVision, which start at $50,000.
This affordability is achieved through the use of a proprietary robotic system that can be connected to any standard optical microscope, as well as through neural network analysis of the video stream directly on a smartphone. Additional advantages include flexible software pricing and easy installation.
Celly is just beginning its export journey, but it is already actively exploring new horizons. The company has begun with neighboring CIS countries and India, where it sees great potential due to the demand for low-cost solutions, a shortage of doctors, and a growing population. Celly products are already supplied to Kazakhstan, India, and Türkiye, with plans to expand its presence in BRICS countries, Southeast Asia, and the MENA region.
Bringing such a complex product to market, especially a medical one, is always challenging due to the high level of regulation. Seeking support, the company turned to Russian Export Center (REC, VEB Group).
"We learned about REC after seeing its stand at the exhibition, approached them, and asked how to participate. Business is a marathon. Government support is like water stations along the route: it helps recovering and continuing on your way to your goal," Celly's management.
Collaboration with Russian Export Center has become a catalyst for export development. Celly has participated in international exhibitions such as ExpoMed Istanbul and KIHE in Tashkent, where REC staff organized high-level meetings with industry-specific companies. All applications for participation in the events were conveniently processed with the Events service on My Export platform.
On the main page of the Events service, exhibitions and business missions are presented in chronological order. One may find the right event filtering them by name, date, country, industry, and market. Each event profile contains all the information an exporter needs: industry, dates of the event and registration, which costs and amounts are eligible for co-financing. By participating in a joint stand under the Made in Russia brand, exporters receive support for space rental reimbursement, stand construction, delivery of exhibition samples, finding and organizing business meetings with potential partners, and more.
Celly recently received the Made in Russia certificate, marking an important step in its international strategy.
"For us, the Made in Russia certificate is not just a quality mark, but a kind of calling card in international markets. It confirms that our products meet high standards and embody the best practices of domestic production," Celly management.
The Made in Russia mark confirms the high standards and quality of products designed and manufactured in the Russian Federation. To get a free Made in Russia certificate, the company does not need to undergo additional checks by Russian Export Center. The certificate is awarded based on five key criteria, namely quality, reliability, uniqueness, environmental friendliness, and organic origin. For more information about the Made in Russia program and certification requirements please visit the REC website.
In 2022, the company released the first version of its product and became a Skolkovo resident. By 2024, Celly device successfully completed clinical trials, demonstrating that its diagnostic accuracy is comparable to competing solutions tens of times more expensive. In 2025, the company underwent certification in the Russian Federation and started active scaling, including expansion into international markets.
Blood smear analysis is one of the most common laboratory tests worldwide, used to diagnose infectious diseases, anemia, and leukemia. Approximately 600 million such tests are performed annually, but most are performed manually due to the high cost of automated systems. Manual analysis suffers from subjectivity, inattention, and a shortage of qualified personnel.
Celly offers an automated yet affordable solution. It's a kit that transforms a standard laboratory microscope into a digital blood smear scanner. It consists of a smartphone with the Celly mobile app, a special lens adapter for connecting to the microscope, a robotic slide handling system, and cloud storage. The product performs automated CBC analysis, replacing manual labor, and is 10 times cheaper than existing solutions from giants like Mindray and CellaVision, which start at $50,000.
This affordability is achieved through the use of a proprietary robotic system that can be connected to any standard optical microscope, as well as through neural network analysis of the video stream directly on a smartphone. Additional advantages include flexible software pricing and easy installation.
Celly is just beginning its export journey, but it is already actively exploring new horizons. The company has begun with neighboring CIS countries and India, where it sees great potential due to the demand for low-cost solutions, a shortage of doctors, and a growing population. Celly products are already supplied to Kazakhstan, India, and Türkiye, with plans to expand its presence in BRICS countries, Southeast Asia, and the MENA region.
Bringing such a complex product to market, especially a medical one, is always challenging due to the high level of regulation. Seeking support, the company turned to Russian Export Center (REC, VEB Group).
"We learned about REC after seeing its stand at the exhibition, approached them, and asked how to participate. Business is a marathon. Government support is like water stations along the route: it helps recovering and continuing on your way to your goal," Celly's management.
Collaboration with Russian Export Center has become a catalyst for export development. Celly has participated in international exhibitions such as ExpoMed Istanbul and KIHE in Tashkent, where REC staff organized high-level meetings with industry-specific companies. All applications for participation in the events were conveniently processed with the Events service on My Export platform.
On the main page of the Events service, exhibitions and business missions are presented in chronological order. One may find the right event filtering them by name, date, country, industry, and market. Each event profile contains all the information an exporter needs: industry, dates of the event and registration, which costs and amounts are eligible for co-financing. By participating in a joint stand under the Made in Russia brand, exporters receive support for space rental reimbursement, stand construction, delivery of exhibition samples, finding and organizing business meetings with potential partners, and more.
Celly recently received the Made in Russia certificate, marking an important step in its international strategy.
"For us, the Made in Russia certificate is not just a quality mark, but a kind of calling card in international markets. It confirms that our products meet high standards and embody the best practices of domestic production," Celly management.
The Made in Russia mark confirms the high standards and quality of products designed and manufactured in the Russian Federation. To get a free Made in Russia certificate, the company does not need to undergo additional checks by Russian Export Center. The certificate is awarded based on five key criteria, namely quality, reliability, uniqueness, environmental friendliness, and organic origin. For more information about the Made in Russia program and certification requirements please visit the REC website.